Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Article
Lassman, Andrew B, Hoang-Xuan, Khe, Polley, Mei-Yin C et al. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
. JOURNAL OF CLINICAL ONCOLOGY, 40(23), 2539-+. 10.1200/JCO.21.02543
Lassman, Andrew B, Hoang-Xuan, Khe, Polley, Mei-Yin C et al. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
. JOURNAL OF CLINICAL ONCOLOGY, 40(23), 2539-+. 10.1200/JCO.21.02543